Portage Biotech Statistics
Total Valuation
PRTG has a market cap or net worth of $5.25 million. The enterprise value is $1.85 million.
Important Dates
The next estimated earnings date is Tuesday, November 26, 2024, after market close.
| Earnings Date | Nov 26, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
PRTG has 1.05 million shares outstanding. The number of shares has increased by 17.18% in one year.
| Shares Outstanding | 1.05M |
| Shares Change (YoY) | +17.18% |
| Shares Change (QoQ) | +0.10% |
| Owned by Insiders (%) | 32.69% |
| Owned by Institutions (%) | 4.22% |
| Float | 595,205 |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 2.33 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.73, with a Debt / Equity ratio of 0.02.
| Current Ratio | 1.73 |
| Quick Ratio | 1.12 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -502.88 |
Financial Efficiency
Return on equity (ROE) is -191.03% and return on invested capital (ROIC) is -26.89%.
| Return on Equity (ROE) | -191.03% |
| Return on Assets (ROA) | -19.41% |
| Return on Capital (ROIC) | -26.89% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$10.15M |
| Employee Count | 7 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -10.40M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -86.88% in the last 52 weeks. The beta is 99.43, so PRTG's price volatility has been higher than the market average.
| Beta (5Y) | 99.43 |
| 52-Week Price Change | -86.88% |
| 50-Day Moving Average | 5.81 |
| 200-Day Moving Average | 7.08 |
| Relative Strength Index (RSI) | 41.54 |
| Average Volume (20 Days) | 86,590 |
Short Selling Information
The latest short interest is 18,824, so 1.79% of the outstanding shares have been sold short.
| Short Interest | 18,824 |
| Short Previous Month | 17,552 |
| Short % of Shares Out | 1.79% |
| Short % of Float | 3.16% |
| Short Ratio (days to cover) | 0.01 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -16.09M |
| Pretax Income | -170.41M |
| Net Income | -71.08M |
| EBITDA | -16.04M |
| EBIT | -16.09M |
| Earnings Per Share (EPS) | -$70.50 |
Full Income StatementBalance Sheet
The company has $3.33 million in cash and $37,000 in debt, giving a net cash position of $3.30 million or $3.14 per share.
| Cash & Cash Equivalents | 3.33M |
| Total Debt | 37,000 |
| Net Cash | 3.30M |
| Net Cash Per Share | $3.14 |
| Equity (Book Value) | 1.81M |
| Book Value Per Share | 2.39 |
| Working Capital | 2.19M |
Full Balance SheetCash Flow
| Operating Cash Flow | -12.53M |
| Capital Expenditures | n/a |
| Free Cash Flow | -12.53M |
| FCF Per Share | -$11.95 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |